25 XP   0   0   10

Xencor Inc
Buy, Hold or Sell?

Let's analyse Xencor together

PenkeI guess you are interested in Xencor Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Xencor Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Xencor Inc

I send you an email if I find something interesting about Xencor Inc.

Quick analysis of Xencor (30 sec.)










What can you expect buying and holding a share of Xencor? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$10.95
Expected worth in 1 year
$9.99
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.95
Return On Investment
-5.0%

For what price can you sell your share?

Current Price per Share
$19.02
Expected price per share
$16.49 - $24.45
How sure are you?
50%

1. Valuation of Xencor (5 min.)




Live pricePrice per Share (EOD)

$19.02

Intrinsic Value Per Share

$1.00 - $6.34

Total Value Per Share

$11.95 - $17.28

2. Growth of Xencor (5 min.)




Is Xencor growing?

Current yearPrevious yearGrowGrow %
How rich?$669.1m$738.8m-$63.7m-9.4%

How much money is Xencor making?

Current yearPrevious yearGrowGrow %
Making money-$31.3m-$15.2m-$16m-51.2%
Net Profit Margin-112.0%-70.1%--

How much money comes from the company's main activities?

3. Financial Health of Xencor (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#82 / 1010

Most Revenue
#164 / 1010

Most Profit
#808 / 1010

Most Efficient
#573 / 1010

What can you expect buying and holding a share of Xencor? (5 min.)

Welcome investor! Xencor's management wants to use your money to grow the business. In return you get a share of Xencor.

What can you expect buying and holding a share of Xencor?

First you should know what it really means to hold a share of Xencor. And how you can make/lose money.

Speculation

The Price per Share of Xencor is $19.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Xencor.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Xencor, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.95. Based on the TTM, the Book Value Change Per Share is $-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Xencor.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-1.6%-0.52-2.7%-0.23-1.2%-0.12-0.6%-0.11-0.6%
Usd Book Value Change Per Share0.000.0%-0.24-1.3%-0.02-0.1%0.120.6%0.241.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.24-1.3%-0.02-0.1%0.120.6%0.241.3%
Usd Price Per Share21.23-23.56-26.52-31.77-26.59-
Price to Earnings Ratio-16.98--13.52--10.05--31.12--27.29-
Price-to-Total Gains Ratio10,549.46-2,515.39-56.31--8.09--296.26-
Price to Book Ratio1.94-2.13-2.19-3.06-4.77-
Price-to-Total Gains Ratio10,549.46-2,515.39-56.31--8.09--296.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share19.02
Number of shares52
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.240.12
Usd Total Gains Per Share-0.240.12
Gains per Quarter (52 shares)-12.416.27
Gains per Year (52 shares)-49.6525.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-50-6002515
20-99-11005040
30-149-16007565
40-199-210010090
50-248-2600125115
60-298-3100151140
70-348-3600176165
80-397-4100201190
90-447-4600226215
100-497-5100251240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%7.033.00.017.5%7.039.00.015.2%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%9.011.00.045.0%15.025.00.037.5%18.026.02.039.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.045.02.2%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%9.011.00.045.0%15.025.00.037.5%18.026.02.039.1%

Fundamentals of Xencor

About Xencor Inc

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It develops Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat non-Hodgkin lymphoma; Vudalimab, a bispecific antibody, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer and other solid tumor types. The company is also developing XmAb306, which is in Phase I clinical trial to treat solid tumors; XmAb104, which is in Phase II clinical trial to treat patients with selected solid tumors; XmAb564 that is in Phase Ia clinical trial to treat autoimmune diseases; AMG 509, which is in Phase I clinical trial to treat prostate cancer; XmAb819 for patients with renal cell carcinoma; XmAb541 for the treatment of ovarian cancer; and XmAb662 which is in Phase I clinical trial to treat patients with solid tumors. In addition, the company develops VIR-3434, which is in Phase II clinical trial for patients with hepatitis B virus infection; and VIR-2482 that is in Phase 2 clinical trial to trat hepatitis B virus. The company develops AIMab7195 to reduce blood serum levels of IgE that mediates allergic responses and allergic disease; Obexelimab to treat autoimmune disease; and Xpro1595 to treat patients with Alzheimer's disease, and depression. It has a license agreement with Caris Life Sciences. Xencor, Inc. was incorporated in 1997 and is headquartered in Pasadena, California.

Fundamental data was last updated by Penke on 2024-04-09 09:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Xencor Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Xencor earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Net Profit Margin of -42.7% means that $-0.43 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Xencor Inc:

  • The MRQ is -42.7%. The company is making a huge loss. -2
  • The TTM is -112.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-42.7%TTM-112.0%+69.3%
TTM-112.0%YOY-70.1%-41.9%
TTM-112.0%5Y-99.9%-12.0%
5Y-99.9%10Y-155.7%+55.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.7%-200.1%+157.4%
TTM-112.0%-216.8%+104.8%
YOY-70.1%-288.3%+218.2%
5Y-99.9%-449.1%+349.2%
10Y-155.7%-605.5%+449.8%
1.1.2. Return on Assets

Shows how efficient Xencor is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • -2.0% Return on Assets means that Xencor generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Xencor Inc:

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-3.9%+1.8%
TTM-3.9%YOY-1.8%-2.0%
TTM-3.9%5Y-1.0%-2.9%
5Y-1.0%10Y-1.7%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%-13.3%+11.3%
TTM-3.9%-12.8%+8.9%
YOY-1.8%-11.7%+9.9%
5Y-1.0%-13.9%+12.9%
10Y-1.7%-15.7%+14.0%
1.1.3. Return on Equity

Shows how efficient Xencor is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • -2.9% Return on Equity means Xencor generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Xencor Inc:

  • The MRQ is -2.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-4.6%+1.8%
TTM-4.6%YOY-2.1%-2.5%
TTM-4.6%5Y-1.2%-3.4%
5Y-1.2%10Y-2.0%+0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-16.9%+14.0%
TTM-4.6%-16.1%+11.5%
YOY-2.1%-15.1%+13.0%
5Y-1.2%-19.3%+18.1%
10Y-2.0%-20.2%+18.2%

1.2. Operating Efficiency of Xencor Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Xencor is operating .

  • Measures how much profit Xencor makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • An Operating Margin of -75.3% means the company generated $-0.75  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Xencor Inc:

  • The MRQ is -75.3%. The company is operating very inefficient. -2
  • The TTM is -124.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-75.3%TTM-124.9%+49.7%
TTM-124.9%YOY-102.3%-22.6%
TTM-124.9%5Y-129.4%+4.5%
5Y-129.4%10Y-174.7%+45.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.3%-296.2%+220.9%
TTM-124.9%-232.5%+107.6%
YOY-102.3%-298.2%+195.9%
5Y-129.4%-492.1%+362.7%
10Y-174.7%-632.4%+457.7%
1.2.2. Operating Ratio

Measures how efficient Xencor is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.75 means that the operating costs are $1.75 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Xencor Inc:

  • The MRQ is 1.753. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.249. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.753TTM2.249-0.497
TTM2.249YOY2.044+0.205
TTM2.2495Y2.785-0.536
5Y2.78510Y4.372-1.586
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7533.231-1.478
TTM2.2493.310-1.061
YOY2.0443.890-1.846
5Y2.7855.739-2.954
10Y4.3727.876-3.504

1.3. Liquidity of Xencor Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Xencor is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.36 means the company has $7.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Xencor Inc:

  • The MRQ is 7.356. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.277. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.356TTM10.277-2.921
TTM10.277YOY8.527+1.750
TTM10.2775Y8.433+1.845
5Y8.43310Y6.919+1.514
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3563.890+3.466
TTM10.2774.173+6.104
YOY8.5275.344+3.183
5Y8.4336.126+2.307
10Y6.9196.448+0.471
1.3.2. Quick Ratio

Measures if Xencor is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Quick Ratio of 13.52 means the company can pay off $13.52 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Xencor Inc:

  • The MRQ is 13.516. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.464. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.516TTM18.464-4.948
TTM18.464YOY14.780+3.684
TTM18.4645Y14.775+3.689
5Y14.77510Y11.083+3.692
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.5163.514+10.002
TTM18.4643.998+14.466
YOY14.7805.380+9.400
5Y14.7756.105+8.670
10Y11.0836.404+4.679

1.4. Solvency of Xencor Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Xencor assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Xencor to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Xencor assets are financed with 29.8% credit (debt) and the remaining percentage (100% - 29.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Xencor Inc:

  • The MRQ is 0.298. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.179. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.179+0.119
TTM0.179YOY0.128+0.050
TTM0.1795Y0.134+0.044
5Y0.13410Y0.165-0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2980.339-0.041
TTM0.1790.336-0.157
YOY0.1280.271-0.143
5Y0.1340.366-0.232
10Y0.1650.389-0.224
1.4.2. Debt to Equity Ratio

Measures if Xencor is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Xencor to the Biotechnology industry mean.
  • A Debt to Equity ratio of 42.4% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Xencor Inc:

  • The MRQ is 0.424. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.227. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.424TTM0.227+0.197
TTM0.227YOY0.148+0.080
TTM0.2275Y0.159+0.069
5Y0.15910Y0.210-0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4240.388+0.036
TTM0.2270.402-0.175
YOY0.1480.335-0.187
5Y0.1590.426-0.267
10Y0.2100.461-0.251

2. Market Valuation of Xencor Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Xencor generates.

  • Above 15 is considered overpriced but always compare Xencor to the Biotechnology industry mean.
  • A PE ratio of -16.98 means the investor is paying $-16.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Xencor Inc:

  • The EOD is -15.216. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.984. Based on the earnings, the company is expensive. -2
  • The TTM is -13.516. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.216MRQ-16.984+1.768
MRQ-16.984TTM-13.516-3.468
TTM-13.516YOY-10.048-3.468
TTM-13.5165Y-31.119+17.603
5Y-31.11910Y-27.289-3.830
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.216-2.264-12.952
MRQ-16.984-2.629-14.355
TTM-13.516-2.680-10.836
YOY-10.048-4.145-5.903
5Y-31.119-6.257-24.862
10Y-27.289-6.254-21.035
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Xencor Inc:

  • The EOD is 1.619. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.807. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -6.815. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1.619MRQ1.807-0.188
MRQ1.807TTM-6.815+8.623
TTM-6.815YOY30.665-37.480
TTM-6.8155Y-1.047-5.768
5Y-1.04710Y-15.766+14.719
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.619-2.973+4.592
MRQ1.807-3.333+5.140
TTM-6.815-3.553-3.262
YOY30.665-5.605+36.270
5Y-1.047-8.376+7.329
10Y-15.766-8.865-6.901
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Xencor is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.94 means the investor is paying $1.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Xencor Inc:

  • The EOD is 1.737. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.939. Based on the equity, the company is underpriced. +1
  • The TTM is 2.130. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.737MRQ1.939-0.202
MRQ1.939TTM2.130-0.191
TTM2.130YOY2.194-0.063
TTM2.1305Y3.058-0.928
5Y3.05810Y4.772-1.714
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7371.896-0.159
MRQ1.9392.115-0.176
TTM2.1302.093+0.037
YOY2.1942.884-0.690
5Y3.0583.542-0.484
10Y4.7723.916+0.856
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Xencor Inc.

3.1. Institutions holding Xencor Inc

Institutions are holding 105.615% of the shares of Xencor Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc18.52630.0061113233108735078.3591
2023-12-31PRIMECAP Management Company14.56410.149689016077174018.7657
2023-12-31Vanguard Group Inc11.0720.003167672491158861.7423
2023-12-31EcoR1 Capital, LLC8.64282.9118528251600
2023-12-31T. Rowe Price Associates, Inc.5.69990.009934837752988419.383
2023-12-31State Street Corporation5.44310.0034332685634825511.6919
2023-12-31FMR Inc4.19320.00422562905-868990-25.321
2023-12-31Armistice Capital, LLC2.45420.43471500000220001.4885
2023-12-31T. Rowe Price Investment Management,Inc.2.2110.01871351367-2426996-64.2341
2023-12-31Geode Capital Management, LLC2.15140.00291314943549914.3645
2023-12-31Dimensional Fund Advisors, Inc.2.09270.00791279077-172270-11.8697
2023-12-31Loomis, Sayles & Company LP1.61690.0321988244-518308-34.4036
2023-12-31Goldman Sachs Group Inc1.43290.0017875800692437377.6318
2023-12-31Johnson & Johnson1.22390.362174806200
2023-12-31Morgan Stanley - Brokerage Accounts1.2190.001474504719342735.0653
2023-12-31Northern Trust Corp1.17620.0028718919446256.618
2023-12-31Candriam Luxembourg S.C.A.1.15830.1038707984550008.4229
2023-12-31Charles Schwab Investment Management Inc0.85190.0028520698322516.6028
2023-12-31Bank of New York Mellon Corp0.83250.0022508851229584.7249
2023-12-31JPMorgan Chase & Co0.820.001501167-3417-0.6772
Total 87.38234.062253408377-518402-1.0%

3.2. Funds holding Xencor Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31PRIMECAP Odyssey Aggressive Growth9.32851.684257015871065601.9045
2024-03-28iShares Core S&P Small-Cap ETF6.72770.11334111968-15272-0.37
2023-12-31PRIMECAP Odyssey Growth3.86280.7318236094038737119.6279
2024-03-28SPDR® S&P Biotech ETF3.12660.56011911013241201.2783
2024-02-29Vanguard Total Stock Mkt Idx Inv3.11560.00281904250-26340-1.3643
2024-02-29Vanguard Small Cap Index2.56720.02561569092145300.9347
2023-12-31US Small-Cap Growth II Equity Comp2.33030.1218142425623783620.0465
2023-12-31T. Rowe Price New Horizons2.33030.1222142425623783620.0465
2024-03-28iShares Russell 2000 ETF2.3180.047914167746840.0483
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.48650.02049085256630.073
2024-02-29Vanguard Small Cap Growth Index Inv1.44110.0579880777146531.6918
2023-12-31T. Rowe Price Small-Cap Value1.30750.1604799158-397200-33.2008
2023-12-31T. Rowe Price Health Sciences1.1440.1009699241-51833-6.9012
2023-12-31Vanguard US Opportunities Ins USD Acc1.06251.099664938582001.2789
2024-01-31Fidelity Small Cap Index0.9520.043958186167421.1723
2024-02-29Loomis Sayles Small Cap Growth Instl0.91250.5583557744-15007-2.6202
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.89270.11485456435500.1009
2023-12-31UBS: US Equity Small Cap Growth0.8760.466753539700
2024-02-29Vanguard Tax-Managed Small Cap Adm0.77780.122847536300
2023-12-31T. Rowe Price Integrated US Sm Gr Eq0.7670.127746880000
Total 47.32666.283128926030+534093+1.8%

3.3. Insider Transactions

Insiders are holding 0.981% of the shares of Xencor Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-11Bassil I DahiyatSELL274123.5
2024-03-11Celia EckertSELL85023.5
2024-03-11John J KuchSELL84923.5
2024-03-11John R DesjarlaisSELL128023.5
2024-03-06Kurt A GustafsonSELL1400023.18
2024-03-05Bassil I DahiyatSELL1252823.43
2024-03-05Celia EckertSELL389223.43
2024-03-05John J KuchSELL447423.43
2024-03-05John R DesjarlaisSELL662923.43
2024-02-13John R DesjarlaisSELL5410819.38
2023-12-29Bassil I DahiyatSELL4500020.93
2023-06-21Bassil I DahiyatSELL3349726.19

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Xencor Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.002-0.239+11962%-0.025+1321%0.121-98%0.244-99%
Book Value Per Share--10.94811.046-1%12.089-9%10.606+3%7.378+48%
Current Ratio--7.35610.277-28%8.527-14%8.433-13%6.919+6%
Debt To Asset Ratio--0.2980.179+67%0.128+132%0.134+121%0.165+81%
Debt To Equity Ratio--0.4240.227+87%0.148+187%0.159+167%0.210+102%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.312-0.516+65%-0.226-28%-0.115-63%-0.111-65%
Free Cash Flow Per Share--2.9370.261+1024%-0.077+103%0.038+7592%0.003+92307%
Free Cash Flow To Equity Per Share--3.3050.366+802%-0.054+102%0.123+2597%0.248+1232%
Gross Profit Margin--0.8200.955-14%1.000-18%0.991-17%0.996-18%
Intrinsic Value_10Y_max--6.337--------
Intrinsic Value_10Y_min--1.003--------
Intrinsic Value_1Y_max--0.149--------
Intrinsic Value_1Y_min--0.028--------
Intrinsic Value_3Y_max--0.817--------
Intrinsic Value_3Y_min--0.147--------
Intrinsic Value_5Y_max--1.933--------
Intrinsic Value_5Y_min--0.335--------
Market Cap1162508106.000-12%1297583969.0001439994268.000-10%1620757555.250-20%1941914171.600-33%1625020696.175-20%
Net Profit Margin---0.427-1.120+162%-0.701+64%-0.999+134%-1.557+264%
Operating Margin---0.753-1.249+66%-1.023+36%-1.294+72%-1.747+132%
Operating Ratio--1.7532.249-22%2.044-14%2.785-37%4.372-60%
Pb Ratio1.737-12%1.9392.130-9%2.194-12%3.058-37%4.772-59%
Pe Ratio-15.216+10%-16.984-13.516-20%-10.048-41%-31.119+83%-27.289+61%
Price Per Share19.020-12%21.23023.560-10%26.518-20%31.772-33%26.587-20%
Price To Free Cash Flow Ratio1.619-12%1.807-6.815+477%30.665-94%-1.047+158%-15.766+972%
Price To Total Gains Ratio9451.285-12%10549.4632515.395+319%56.309+18635%-8.094+100%-296.259+103%
Quick Ratio--13.51618.464-27%14.780-9%14.775-9%11.083+22%
Return On Assets---0.020-0.039+92%-0.018-9%-0.010-51%-0.017-14%
Return On Equity---0.029-0.046+62%-0.021-26%-0.012-59%-0.020-31%
Total Gains Per Share--0.002-0.239+11962%-0.025+1321%0.121-98%0.244-99%
Usd Book Value--669133000.000675150500.000-1%738889500.000-9%648237250.000+3%450968025.000+48%
Usd Book Value Change Per Share--0.002-0.239+11962%-0.025+1321%0.121-98%0.244-99%
Usd Book Value Per Share--10.94811.046-1%12.089-9%10.606+3%7.378+48%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.312-0.516+65%-0.226-28%-0.115-63%-0.111-65%
Usd Free Cash Flow--179500000.00015965000.000+1024%-4729750.000+103%2333550.000+7592%194250.000+92307%
Usd Free Cash Flow Per Share--2.9370.261+1024%-0.077+103%0.038+7592%0.003+92307%
Usd Free Cash Flow To Equity Per Share--3.3050.366+802%-0.054+102%0.123+2597%0.248+1232%
Usd Market Cap1162508106.000-12%1297583969.0001439994268.000-10%1620757555.250-20%1941914171.600-33%1625020696.175-20%
Usd Price Per Share19.020-12%21.23023.560-10%26.518-20%31.772-33%26.587-20%
Usd Profit---19100000.000-31309750.000+64%-15289250.000-20%-7311150.000-62%-6898725.000-64%
Usd Revenue--44689000.00042084500.000+6%41144750.000+9%44371100.000+1%27213450.000+64%
Usd Total Gains Per Share--0.002-0.239+11962%-0.025+1321%0.121-98%0.244-99%
 EOD+3 -5MRQTTM+22 -12YOY+18 -165Y+15 -1910Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Xencor Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.216
Price to Book Ratio (EOD)Between0-11.737
Net Profit Margin (MRQ)Greater than0-0.427
Operating Margin (MRQ)Greater than0-0.753
Quick Ratio (MRQ)Greater than113.516
Current Ratio (MRQ)Greater than17.356
Debt to Asset Ratio (MRQ)Less than10.298
Debt to Equity Ratio (MRQ)Less than10.424
Return on Equity (MRQ)Greater than0.15-0.029
Return on Assets (MRQ)Greater than0.05-0.020
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Xencor Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.189
Ma 20Greater thanMa 5020.376
Ma 50Greater thanMa 10022.005
Ma 100Greater thanMa 20021.058
OpenGreater thanClose18.390
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -6,9523,327-3,6251,765-1,8601,151-7092,0001,291
Income Tax Expense  -415-432-847-2,038-2,885-255-3,1408,9515,811



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets952,692
Total Liabilities283,559
Total Stockholder Equity668,796
 As reported
Total Liabilities 283,559
Total Stockholder Equity+ 668,796
Total Assets = 952,692

Assets

Total Assets952,692
Total Current Assets623,160
Long-term Assets329,532
Total Current Assets
Cash And Cash Equivalents 53,790
Short-term Investments 539,935
Net Receivables 11,290
Other Current Assets 18,145
Total Current Assets  (as reported)623,160
Total Current Assets  (calculated)623,160
+/-0
Long-term Assets
Property Plant Equipment 100,119
Long Term Investments 209,722
Intangible Assets 18,663
Long-term Assets Other 648
Long-term Assets  (as reported)329,532
Long-term Assets  (calculated)329,152
+/- 380

Liabilities & Shareholders' Equity

Total Current Liabilities84,709
Long-term Liabilities198,850
Total Stockholder Equity668,796
Total Current Liabilities
Short-term Debt 9,767
Short Long Term Debt 6,332
Accounts payable 13,914
Other Current Liabilities 29,346
Total Current Liabilities  (as reported)84,709
Total Current Liabilities  (calculated)59,359
+/- 25,350
Long-term Liabilities
Long term Debt 14,642
Capital Lease Obligations 62,460
Long-term Liabilities  (as reported)198,850
Long-term Liabilities  (calculated)77,102
+/- 121,748
Total Stockholder Equity
Common Stock611
Retained Earnings -464,372
Accumulated Other Comprehensive Income 1,291
Other Stockholders Equity 1,131,266
Total Stockholder Equity (as reported)668,796
Total Stockholder Equity (calculated)668,796
+/-0
Other
Capital Stock611
Cash and Short Term Investments 593,725
Common Stock Shares Outstanding 60,848
Current Deferred Revenue31,682
Liabilities and Stockholders Equity 952,692
Net Debt 29,644
Net Invested Capital 689,770
Net Working Capital 538,451
Property Plant and Equipment Gross 136,345
Short Long Term Debt Total 83,434



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-30
> Total Assets 
0
11,659
0
21,330
20,206
87,315
82,495
76,367
70,866
67,823
178,639
172,563
211,481
206,910
193,961
334,281
322,130
428,563
418,303
416,164
398,255
390,102
612,272
591,457
585,586
576,732
697,003
684,753
686,244
670,250
666,963
644,720
646,349
703,244
692,737
695,602
697,264
838,211
857,922
851,325
835,269
846,266
803,411
778,121
778,430
952,692
952,692778,430778,121803,411846,266835,269851,325857,922838,211697,264695,602692,737703,244646,349644,720666,963670,250686,244684,753697,003576,732585,586591,457612,272390,102398,255416,164418,303428,563322,130334,281193,961206,910211,481172,563178,63967,82370,86676,36782,49587,31520,20621,330011,6590
   > Total Current Assets 
0
2,839
0
11,989
10,754
78,094
73,206
66,680
61,105
57,749
145,068
69,720
129,876
97,675
94,851
243,651
110,842
141,653
166,089
210,982
217,810
230,879
470,919
269,527
286,920
315,727
488,671
527,009
573,765
558,405
588,107
603,386
570,883
637,672
591,168
480,967
329,629
424,368
505,970
585,936
667,998
675,342
629,976
593,562
571,176
623,160
623,160571,176593,562629,976675,342667,998585,936505,970424,368329,629480,967591,168637,672570,883603,386588,107558,405573,765527,009488,671315,727286,920269,527470,919230,879217,810210,982166,089141,653110,842243,65194,85197,675129,87669,720145,06857,74961,10566,68073,20678,09410,75411,98902,8390
       Cash And Cash Equivalents 
0
2,312
0
11,748
9,621
77,975
72,536
66,218
60,923
54,649
119,048
11,171
57,738
12,590
8,150
7,877
14,787
14,528
13,561
11,220
13,634
16,528
251,572
35,292
34,996
26,246
21,858
32,557
51,189
50,312
73,808
109,534
58,094
163,544
176,965
115,842
41,200
143,480
78,267
49,410
52,654
53,942
72,394
34,710
52,733
53,790
53,79052,73334,71072,39453,94252,65449,41078,267143,48041,200115,842176,965163,54458,094109,53473,80850,31251,18932,55721,85826,24634,99635,292251,57216,52813,63411,22013,56114,52814,7877,8778,15012,59057,73811,171119,04854,64960,92366,21872,53677,9759,62111,74802,3120
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
25,187
56,714
70,206
83,840
84,209
83,228
89,518
115,608
141,225
177,269
196,318
207,603
210,838
220,116
236,605
268,115
318,498
472,613
495,292
479,470
500,094
476,725
493,070
439,459
375,014
334,206
247,001
190,627
311,488
462,508
547,582
569,120
515,628
516,662
441,799
539,935
539,935441,799516,662515,628569,120547,582462,508311,488190,627247,001334,206375,014439,459493,070476,725500,094479,470495,292472,613318,498268,115236,605220,116210,838207,603196,318177,269141,225115,60889,51883,22884,20983,84070,20656,71425,1870000000000
       Net Receivables 
0
354
0
0
0
59
511
60
20
2,966
411
1,124
1,067
44
649
150,354
3,089
8,616
6,938
14,876
831
1,142
1,860
1,283
2,462
10,991
138,882
10,532
19,751
22,076
7,729
9,729
9,534
23,943
25,025
15,325
20,545
66,384
93,204
54,284
44,876
28,997
19,861
20,019
55,000
11,290
11,29055,00020,01919,86128,99744,87654,28493,20466,38420,54515,32525,02523,9439,5349,7297,72922,07619,75110,532138,88210,9912,4621,2831,8601,14283114,8766,9388,6163,089150,354649441,0671,1244112,9662060511590003540
       Other Current Assets 
0
173
0
241
1,133
119
159
462
162
3,100
833
711
1,932
1,245
1,843
2,192
3,448
2,901
4,365
7,617
7,027
5,606
6,649
12,836
12,857
10,375
9,433
11,307
7,533
6,547
6,476
7,398
10,185
10,726
14,164
15,594
20,883
23,877
23,011
19,734
22,886
23,283
22,093
22,171
21,644
18,145
18,14521,64422,17122,09323,28322,88619,73423,01123,87720,88315,59414,16410,72610,1857,3986,4766,5477,53311,3079,43310,37512,85712,8366,6495,6067,0277,6174,3652,9013,4482,1921,8431,2451,9327118333,1001624621591191,13324101730
   > Long-term Assets 
0
8,820
0
9,341
9,452
9,221
9,289
9,687
9,761
10,074
33,571
102,843
81,605
109,235
99,110
90,630
211,288
286,910
252,214
205,182
180,445
159,223
141,353
321,930
298,666
261,005
208,332
157,744
112,479
111,845
78,856
41,334
75,466
65,572
101,569
214,635
367,635
413,843
351,952
265,389
167,271
170,924
173,435
184,559
206,876
329,532
329,532206,876184,559173,435170,924167,271265,389351,952413,843367,635214,635101,56965,57275,46641,33478,856111,845112,479157,744208,332261,005298,666321,930141,353159,223180,445205,182252,214286,910211,28890,63099,110109,23581,605102,84333,57110,0749,7619,6879,2899,2219,4529,34108,8200
       Property Plant Equipment 
0
283
0
367
339
307
340
571
744
899
1,375
1,804
2,293
2,310
2,510
2,508
3,050
3,105
3,360
3,861
6,085
7,088
8,921
9,401
9,688
11,813
11,456
12,128
13,868
25,185
25,676
24,716
28,122
32,282
22,301
23,132
24,179
59,970
59,330
70,295
70,720
93,602
100,382
101,043
102,842
100,119
100,119102,842101,043100,38293,60270,72070,29559,33059,97024,17923,13222,30132,28228,12224,71625,67625,18513,86812,12811,45611,8139,6889,4018,9217,0886,0853,8613,3603,1053,0502,5082,5102,3102,2931,8041,37589974457134030733936702830
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
96,891
86,357
77,666
197,570
273,340
237,865
190,242
163,052
140,722
120,851
300,733
276,990
236,912
172,874
121,368
74,397
71,928
38,232
1,145
31,768
17,101
53,301
170,765
293,326
331,727
5,000
5,000
5,000
58,209
54,210
64,210
84,630
209,722
209,72284,63064,21054,21058,2095,0005,0005,000331,727293,326170,76553,30117,10131,7681,14538,23271,92874,397121,368172,874236,912276,990300,733120,851140,722163,052190,242237,865273,340197,57077,66686,35796,8910000000000000
       Intangible Assets 
0
8,460
0
0
9,013
8,814
8,899
9,058
8,957,000
9,116
9,509
9,691
9,617
9,971
10,140
10,353
10,565
10,362
10,886
10,865
11,043
11,148
11,316
11,531
11,677
11,969
12,737
13,522
14,027
14,421
14,637
15,162
15,319
15,977
15,550
16,384
16,675
16,493
16,712
17,944
18,094
18,500
18,244
18,708
18,744
18,663
18,66318,74418,70818,24418,50018,09417,94416,71216,49316,67516,38415,55015,97715,31915,16214,63714,42114,02713,52212,73711,96911,67711,53111,31611,14811,04310,86510,88610,36210,56510,35310,1409,9719,6179,6919,5099,1168,957,0009,0588,8998,8149,013008,4600
       Other Assets 
0
8,537
0
0
9,113
8,914
8,949
9,116
9,017
9,175
32,196
101,039
79,312
106,925
96,600
88,122
208,238
283,805
248,854
201,321
174,360
152,135
1,027
1,027
1,073
1,115
11,265
11,128
10,589
713
9,188
8,788
8,608
212
10,417
4,354
33,455
5,653
5,613
5,613
5,613
613
599
598
378
0
03785985996135,6135,6135,6135,65333,4554,35410,4172128,6088,7889,18871310,58911,12811,2651,1151,0731,0271,027152,135174,360201,321248,854283,805208,23888,12296,600106,92579,312101,03932,1969,1759,0179,1168,9498,9149,113008,5370
> Total Liabilities 
0
31,161
0
17,336
15,634
13,781
12,430
10,851
11,157
8,533
9,337
10,495
58,166
44,478
35,148
125,684
119,710
114,609
114,555
114,799
107,716
108,056
74,608
72,278
53,313
55,051
87,438
76,662
76,007
77,049
73,958
74,075
77,866
130,800
109,125
48,664
78,404
104,707
94,899
108,984
112,571
118,770
119,828
99,245
109,420
283,559
283,559109,42099,245119,828118,770112,571108,98494,899104,70778,40448,664109,125130,80077,86674,07573,95877,04976,00776,66287,43855,05153,31372,27874,608108,056107,716114,799114,555114,609119,710125,68435,14844,47858,16610,4959,3378,53311,15710,85112,43013,78115,63417,336031,1610
   > Total Current Liabilities 
0
25,479
0
7,130
8,627
7,479
6,827
5,946
9,930
6,196
6,877
8,408
56,576
43,429
34,255
115,953
110,666
106,286
106,875
107,431
100,326
101,345
73,431
71,156
52,027
53,853
73,321
63,712
64,312
66,558
65,917
66,449
70,488
121,061
99,931
45,962
44,317
70,738
60,941
75,041
90,032
63,844
65,056
44,630
53,041
84,709
84,70953,04144,63065,05663,84490,03275,04160,94170,73844,31745,96299,931121,06170,48866,44965,91766,55864,31263,71273,32153,85352,02771,15673,431101,345100,326107,431106,875106,286110,666115,95334,25543,42956,5768,4086,8776,1969,9305,9466,8277,4798,6277,130025,4790
       Short-term Debt 
0
20,930
0
7
7
9
7
5
2
0
0
0
0
0
0
1,781
400
6,692
175
455
-4,636
5,480
0
5,923
5,671
9,662
1,987
2,214
2,197
2,169
2,136
2,094
2,158
1,889
1,934
2,322
128
33,969
936
7,647
20,551
4,708
4,471
4,228
4,380
9,767
9,7674,3804,2284,4714,70820,5517,64793633,9691282,3221,9341,8892,1582,0942,1362,1692,1972,2141,9879,6625,6715,92305,480-4,6364551756,6924001,781000000257977020,9300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,987
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,332
6,3320000000000000000001,98700000000000000000000000000
       Accounts payable 
0
1,315
0
2,776
3,361
2,633
2,104
1,374
2,098
1,691
2,556
3,077
5,107
6,400
4,291
7,694
7,334
3,880
4,275
7,379
11,238
6,869
8,523
4,916
5,983
3,797
5,485
15,220
8,304
10,189
10,313
10,513
13,109
8,954
7,663
7,112
9,131
14,001
11,905
15,747
14,618
10,088
15,341
14,097
14,967
13,914
13,91414,96714,09715,34110,08814,61815,74711,90514,0019,1317,1127,6638,95413,10910,51310,31310,1898,30415,2205,4853,7975,9834,9168,5236,86911,2387,3794,2753,8807,3347,6944,2916,4005,1073,0772,5561,6912,0981,3742,1042,6333,3612,77601,3150
       Other Current Liabilities 
0
1,286
0
915
789
1,393
1,465
1,331
1,764
2,251
1,705
2,537
3,817
3,742
2,504
3,415
6,658
193
6,637
3,984
4,636
183
4,790
199
294
315
6,605
800
8,232
8,995
7,292
9,157
11,381
17,603
12,513
17,328
22,108
19,443
12,612
16,348
19,677
18,728
15,140
18,440
24,472
29,346
29,34624,47218,44015,14018,72819,67716,34812,61219,44322,10817,32812,51317,60311,3819,1577,2928,9958,2328006,6053152941994,7901834,6363,9846,6371936,6583,4152,5043,7423,8172,5371,7052,2511,7641,3311,4651,39378991501,2860
   > Long-term Liabilities 
0
5,682
0
10,206
7,007
6,302
5,603
4,905
1,227
2,337
2,460
2,087
1,590
1,049
893
9,731
9,044
8,323
7,680
7,368
7,390
6,711
1,177
1,122
1,286
1,198
14,117
12,950
11,695
10,491
8,041
7,626
7,378
9,739
9,194
2,702
34,087
33,969
33,958
33,943
22,539
54,926
54,772
54,615
56,379
198,850
198,85056,37954,61554,77254,92622,53933,94333,95833,96934,0872,7029,1949,7397,3787,6268,04110,49111,69512,95014,1171,1981,2861,1221,1776,7117,3907,3687,6808,3239,0449,7318931,0491,5902,0872,4602,3371,2274,9055,6036,3027,00710,20605,6820
       Other Liabilities 
0
5,672
0
0
7,000
6,302
5,603
4,905
1,227
2,337
2,460
2,087
1,590
1,049
893
9,731
9,044
8,323
7,680
7,368
7,390
6,711
1,177
1,122
1,286
1,198
3,896
3,300
2,613
1,926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,9262,6133,3003,8961,1981,2861,1221,1776,7117,3907,3687,6808,3239,0449,7318931,0491,5902,0872,4602,3371,2274,9055,6036,3027,000005,6720
       Deferred Long Term Liability 
0
0
0
0
0
0
5,603
4,905
1,227
2,337
2,460
2,087
1,590
1,049
893
9,731
9,044
8,323
7,680
7,368
7,390
6,711
1,177
1,122
1,286
1,198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,1981,2861,1221,1776,7117,3907,3687,6808,3239,0449,7318931,0491,5902,0872,4602,3371,2274,9055,603000000
> Total Stockholder Equity
0
-19,502
0
3,994
4,572
73,534
70,065
65,516
59,709
59,290
169,302
162,068
153,315
162,432
158,813
208,597
202,420
313,954
303,748
301,365
290,539
282,046
537,664
519,179
532,273
521,681
609,565
608,091
610,237
593,201
593,005
570,645
568,483
572,444
583,612
646,938
618,860
733,504
763,023
742,341
722,698
727,496
683,583
678,876
669,010
668,796
668,796669,010678,876683,583727,496722,698742,341763,023733,504618,860646,938583,612572,444568,483570,645593,005593,201610,237608,091609,565521,681532,273519,179537,664282,046290,539301,365303,748313,954202,420208,597158,813162,432153,315162,068169,30259,29059,70965,51670,06573,5344,5723,9940-19,5020
   Common Stock
0
1
0
2
1
314
314
314
314
314
404
405
405
405
407
409
411
466
467
468
470
470
556
558
562
563
564
565
567
569
570
572
573
580
583
584
585
595
596
598
598
601
605
607
607
611
61160760760560159859859659558558458358057357257056956756556456356255855647047046846746641140940740540540540431431431431431412010
   Retained Earnings Total Equity00-421,002-399,0480-326,244-293,485-259,510-283,104-356,165-315,974-368,222-365,735-352,044-339,494-304,476-296,402-269,490-259,266-243,232-323,277-305,078-308,229-282,361-287,286-275,443-259,880-252,996-237,960-228,895-220,818-267,983-261,585-269,342-259,305-250,437-243,993-242,644-236,366-231,322000000
   Accumulated Other Comprehensive Income 
0
-6,279
0
-6,318
-6,346
-6,377
-6,410
-6,438
-6,489
-6,554
-35
-90
-6
-516
103
216
-250
-1,441
-1,196
-1,240
-1,097
-1,808
-2,201
-2,008
-2,338
-971
345
1,629
1,436
1,161
1,056
1,483
567
74
97
-15
-74
-1,510
-7,121
-8,944
-9,875
-6,952
-3,625
-1,860
-709
1,291
1,291-709-1,860-3,625-6,952-9,875-8,944-7,121-1,510-74-1597745671,4831,0561,1611,4361,629345-971-2,338-2,008-2,201-1,808-1,097-1,240-1,196-1,441-250216103-516-6-90-35-6,554-6,489-6,438-6,410-6,377-6,346-6,3180-6,2790
   Capital Surplus 
0
0
0
0
0
0
301,073
301,568
302,039
302,969
419,370
421,058
422,258
424,128
426,286
428,790
431,154
552,889
557,473
562,017
566,609
570,670
821,670
828,858
839,127
845,366
851,888
865,163
877,724
887,873
895,855
908,084
919,387
937,525
951,154
962,343
974,514
1,017,523
1,029,058
1,044,172
1,058,219
0
1,085,651
1,101,131
0
0
001,101,1311,085,65101,058,2191,044,1721,029,0581,017,523974,514962,343951,154937,525919,387908,084895,855887,873877,724865,163851,888845,366839,127828,858821,670570,670566,609562,017557,473552,889431,154428,790426,286424,128422,258421,058419,370302,969302,039301,568301,073000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
7,322
0
157,494
155,184
307,167
307,483
308,006
308,528
309,523
419,370
421,058
422,258
424,128
426,286
428,790
431,154
552,889
557,473
562,017
566,609
570,670
821,670
828,858
839,127
845,366
851,888
865,163
877,724
887,873
895,855
908,084
919,387
571,790
951,154
962,343
974,514
1,017,523
1,029,058
1,044,172
1,058,219
1,072,132
1,085,651
1,101,131
1,114,383
1,131,266
1,131,2661,114,3831,101,1311,085,6511,072,1321,058,2191,044,1721,029,0581,017,523974,514962,343951,154571,790919,387908,084895,855887,873877,724865,163851,888845,366839,127828,858821,670570,670566,609562,017557,473552,889431,154428,790426,286424,128422,258421,058419,370309,523308,528308,006307,483307,167155,184157,49407,3220



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue168,338
Cost of Revenue-11,498
Gross Profit156,840156,840
 
Operating Income (+$)
Gross Profit156,840
Operating Expense-295,479
Operating Income-138,639-138,639
 
Operating Expense (+$)
Research Development253,598
Selling General Administrative53,379
Selling And Marketing Expenses-11,498
Operating Expense295,479295,479
 
Net Interest Income (+$)
Interest Income13,740
Interest Expense-0
Other Finance Cost-0
Net Interest Income13,740
 
Pretax Income (+$)
Operating Income-138,639
Net Interest Income13,740
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-120,439-156,839
EBIT - interestExpense = -138,639
-120,276
-126,087
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-138,639-120,439
Earnings Before Interest and Taxes (EBITDA)-127,141
 
After tax Income (+$)
Income Before Tax-120,439
Tax Provision--415
Net Income From Continuing Ops-119,028-120,024
Net Income-126,087
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses306,977
Total Other Income/Expenses Net18,200-13,740
 

Technical Analysis of Xencor
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Xencor. The general trend of Xencor is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Xencor's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Xencor Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 20.80 < 21.49 < 24.45.

The bearish price targets are: 17.82 > 16.49.

Tweet this
Xencor Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Xencor Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Xencor Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Xencor Inc. The current macd is -0.98623199.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Xencor price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Xencor. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Xencor price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Xencor Inc Daily Moving Average Convergence/Divergence (MACD) ChartXencor Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Xencor Inc. The current adx is 31.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Xencor shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Xencor Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Xencor Inc. The current sar is 21.21.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Xencor Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Xencor Inc. The current rsi is 37.19. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Xencor Inc Daily Relative Strength Index (RSI) ChartXencor Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Xencor Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Xencor price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Xencor Inc Daily Stochastic Oscillator ChartXencor Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Xencor Inc. The current cci is -93.56599629.

Xencor Inc Daily Commodity Channel Index (CCI) ChartXencor Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Xencor Inc. The current cmo is -26.29192934.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Xencor Inc Daily Chande Momentum Oscillator (CMO) ChartXencor Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Xencor Inc. The current willr is -74.18967587.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Xencor is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Xencor Inc Daily Williams %R ChartXencor Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Xencor Inc.

Xencor Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Xencor Inc. The current atr is 0.89971517.

Xencor Inc Daily Average True Range (ATR) ChartXencor Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Xencor Inc. The current obv is -2,741,000.

Xencor Inc Daily On-Balance Volume (OBV) ChartXencor Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Xencor Inc. The current mfi is 40.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Xencor Inc Daily Money Flow Index (MFI) ChartXencor Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Xencor Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Xencor Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Xencor Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.189
Ma 20Greater thanMa 5020.376
Ma 50Greater thanMa 10022.005
Ma 100Greater thanMa 20021.058
OpenGreater thanClose18.390
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Xencor with someone you think should read this too:
  • Are you bullish or bearish on Xencor? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Xencor? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Xencor Inc

I send you an email if I find something interesting about Xencor Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Xencor Inc.

Receive notifications about Xencor Inc in your mailbox!